Despite a challenging funding landscape, 2026 has seen two groundbreaking advances in mRNA vaccine discovery; the first-ever mRNA seasonal influenza vaccine for adults and the first positive Phase III readout for an mRNA-based cancer therapy.
This eBook explores how the mRNA platform has evolved since its use in Covid-19 vaccines, from the prevention of seasonal illnesses to personalised therapies for a range of diseases.
Download now to read articles on:
-
Why 2026 has been a momentous year for mRNA vaccines
-
The innovation and opportunity for cancer vaccines
-
The promise of regulatory RNAs and antisense oligonucleotides
-
How enzymatic DNA synthesis is unlocking inaccessible regions of the genome
